ABISA Engaged for Southeast Asia Cancer Hospital

Tampa, FL, October 23, 2019 --(PR.com)-- ABISA, LLC, a leading independent healthcare consultancy,
announced that the company has been engaged by a private entity to develop a strategy around building a
cancer hospital in one of the countries in Southeast Asia.

In addition to its longstanding U.S. client base, ABISA also has worked with clients in the United
Kingdom, Canada, United Arab Emirates, Virgin Islands, Australia, South Africa, Switzerland, Morocco,
Puerto Rico, and Turkey. “We are excited to have been asked to advance this unique strategic oncology
initiative,” says Nick Hernandez, CEO at ABISA. "ABISA's niche within the healthcare industry
positions us well for the strategic needs of our clients.”

Investors and healthcare providers are seeking support for a variety of strategic business initiatives to
expand markets. ABISA is an ideal partner to provide that consulting support. The company's success can
be attributed to its culture that focuses on professionalism and emphasizes long-term client relationships.
“We are very humbled to be able to help those who seek to fight cancer in every corner of the world,”
Hernandez said. “The global healthcare sector is ever-changing. Selecting the right partner to support
critical initiatives is so important. Our integrity and focused expertise allows our clients to be confident
that ABISA will provide the sound advice that they expect.”

About ABISA
ABISA is a global healthcare consultancy specializing in healthcare strategy and physician engagement,
healthcare investment initiatives, and global oncology initiatives. ABISA can help devise and implement
the strategies and processes that will allow organizations to remain competitive and solvent. For more
information, visit www.abisallc.com or contact us at info@abisallc.com.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
ABISA
Nick Hernandez
813-486-6449
Contact via Email
www.abisallc.com

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/797622

Page 2/2
PR.com Press Release Distribution Terms of Use